{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T22:46:47Z","timestamp":1783464407021,"version":"3.55.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T00:00:00Z","timestamp":1628467200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T00:00:00Z","timestamp":1628467200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"University of Innsbruck and Medical University of Innsbruck"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurocrit Care"],"published-print":{"date-parts":[[2022,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The amount of intracranial blood is a strong predictor of poor outcome after subarachnoid hemorrhage (SAH). Here, we aimed to measure iron concentrations in the cerebral white matter, using the cerebral microdialysis (CMD) technique, and to associate iron levels with the local metabolic profile, complications, and functional outcome.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>For the observational cohort study, 36 patients with consecutive poor grade SAH (Hunt &amp; Hess grade of 4 or 5, Glasgow Coma Scale Score\u2009\u2264\u20098) undergoing multimodal neuromonitoring were analyzed for brain metabolic changes, including CMD iron levels quantified by graphite furnace atomic absorption spectrometry. The study time encompassed 14 days after admission. Statistical analysis was performed using generalized estimating equations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Patients were admitted in a poor clinical grade (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200926, 72%) or deteriorated within 24\u00a0h (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200910, 28%). The median blood volume in the subarachnoid space was high (SAH sum score\u2009=\u200926, interquartile range 20\u201328). Initial CMD iron was 44\u00a0\u00b5g\/L (25\u201365\u00a0\u00b5g\/L), which significantly decreased to a level of 25\u00a0\u00b5g\/L (14\u201330\u00a0\u00b5g\/L) at day 4 and then constantly increased over the remaining neuromonitoring days (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.01). A higher intraventricular hemorrhage sum score (\u2265\u20095) was associated with higher CMD iron levels (Wald-statistic\u2009=\u20094.1, df\u2009 = 1,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.04) but not with the hemorrhage load in the subarachnoid space (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.8). In patients developing vasospasm, the CMD iron load was higher, compared with patients without vasospasm (Wald-statistic\u2009=\u20094.1, degree of freedom\u2009=\u20091,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.04), which was not true for delayed cerebral infarction (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.4). Higher iron concentrations in the brain extracellular fluid (34\u00a0\u00b5g\/L, 36\u201356\u00a0\u00b5g\/L vs. 23\u00a0\u00b5g\/L, 15\u201337\u00a0\u00b5g\/L) were associated with mitochondrial dysfunction (CMD lactate to pyruvate ratio\u2009&gt;\u200930 and CMD-pyruvate\u2009&gt;\u200970\u00a0\u00b5M\/L,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001). Brain extracellular iron load was not associated with functional outcome after 3\u00a0months (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&gt;\u20090.5).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This study suggests that iron accumulates in the cerebral white matter in patients with poor grade SAH. These findings may support trials aiming to scavenger brain extracellular iron based on the hypothesis that iron-mediated neurotoxicity may contribute to acute and secondary brain injury following SAH.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s12028-021-01278-1","type":"journal-article","created":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T14:25:01Z","timestamp":1628519101000},"page":"171-179","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Intracerebral Iron Accumulation may be Associated with Secondary Brain Injury in Patients with Poor Grade Subarachnoid Hemorrhage"],"prefix":"10.1007","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5682-0145","authenticated-orcid":false,"given":"Raimund","family":"Helbok","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Verena","family":"Rass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Kofler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heribert","family":"Talasz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alois","family":"Schiefecker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Max","family":"Gaasch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Scherfler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bettina","family":"Pfausler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudius","family":"Thom\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronny","family":"Beer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herbert H.","family":"Lindner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erich","family":"Schmutzhard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,8,9]]},"reference":[{"issue":"3","key":"1278_CR1","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1136\/jnnp-2012-302804","volume":"84","author":"R Helbok","year":"2013","unstructured":"Helbok R, Kurtz P, Vibbert M, et al. Early neurological deterioration after subarachnoid haemorrhage: risk factors and impact on outcome. J Neurol Neurosurg Psychiatry. 2013;84(3):266\u201370.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"9","key":"1278_CR2","doi-asserted-by":"publisher","first-page":"2012","DOI":"10.1161\/hs0901.095677","volume":"32","author":"J Claassen","year":"2001","unstructured":"Claassen J, Bernardini GL, Kreiter K, et al. Effect of cisternal and ventricular blood on risk of delayed cerebral ischemia after subarachnoid hemorrhage: the Fisher scale revisited. Stroke. 2001;32(9):2012\u201320.","journal-title":"Stroke"},{"issue":"6","key":"1278_CR3","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1161\/01.STR.24.6.809","volume":"24","author":"PJ Brouwers","year":"1993","unstructured":"Brouwers PJ, Dippel DW, Vermeulen M, et al. Amount of blood on computed tomography as an independent predictor after aneurysm rupture. Stroke. 1993;24(6):809\u201314.","journal-title":"Stroke"},{"issue":"10","key":"1278_CR4","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1161\/01.STR.19.10.1250","volume":"19","author":"A Hijdra","year":"1988","unstructured":"Hijdra A, van Gijn J, Nagelkerke NJ, Vermeulen M, van Crevel H. Prediction of delayed cerebral ischemia, rebleeding, and outcome after aneurysmal subarachnoid hemorrhage. Stroke. 1988;19(10):1250\u20136.","journal-title":"Stroke"},{"issue":"Pt 2","key":"1278_CR5","first-page":"95","volume":"110","author":"D Hanggi","year":"2011","unstructured":"Hanggi D, Steiger HJ. The influence of cisternal and ventricular lavage on cerebral vasospasm in patients suffering from subarachnoid hemorrhage: analysis of effectiveness. Acta Neurochir Suppl. 2011;110(Pt 2):95\u20138.","journal-title":"Acta Neurochir Suppl"},{"issue":"3","key":"1278_CR6","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1161\/STROKEAHA.111.625731","volume":"43","author":"YZ Al-Tamimi","year":"2012","unstructured":"Al-Tamimi YZ, Bhargava D, Feltbower RG, et al. Lumbar drainage of cerebrospinal fluid after aneurysmal subarachnoid hemorrhage: a prospective, randomized, controlled trial (LUMAS). Stroke. 2012;43(3):677\u201382.","journal-title":"Stroke"},{"issue":"3","key":"1278_CR7","doi-asserted-by":"publisher","first-page":"408","DOI":"10.3171\/jns.1999.91.3.0408","volume":"91","author":"M Shimoda","year":"1999","unstructured":"Shimoda M, Oda S, Shibata M, et al. Results of early surgical evacuation of packed intraventricular hemorrhage from aneurysm rupture in patients with poor-grade subarachnoid hemorrhage. J Neurosurg. 1999;91(3):408\u201314.","journal-title":"J Neurosurg"},{"key":"1278_CR8","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1016\/j.wneu.2017.08.088","volume":"107","author":"N Ota","year":"2017","unstructured":"Ota N, Matsukawa H, Kamiyama H, et al. Preventing cerebral vasospasm after aneurysmal subarachnoid hemorrhage with aggressive cisternal clot removal and nicardipine. World Neurosurg. 2017;107:630\u201340.","journal-title":"World Neurosurg"},{"key":"1278_CR9","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1186\/1745-6215-12-203","volume":"12","author":"J Bardutzky","year":"2011","unstructured":"Bardutzky J, Witsch J, Juttler E, et al. EARLYDRAIN- outcome after early lumbar CSF-drainage in aneurysmal subarachnoid hemorrhage: study protocol for a randomized controlled trial. Trials. 2011;12:203.","journal-title":"Trials"},{"key":"1278_CR10","doi-asserted-by":"publisher","first-page":"187","DOI":"10.3389\/fphys.2015.00187","volume":"6","author":"A Smith","year":"2015","unstructured":"Smith A, McCulloh RJ. Hemopexin and haptoglobin: allies against heme toxicity from hemoglobin not contenders. Front Physiol. 2015;6:187.","journal-title":"Front Physiol"},{"key":"1278_CR11","doi-asserted-by":"publisher","first-page":"415","DOI":"10.3389\/fphys.2014.00415","volume":"5","author":"DJ Schaer","year":"2014","unstructured":"Schaer DJ, Vinchi F, Ingoglia G, Tolosano E, Buehler PW. Haptoglobin, hemopexin, and related defense pathways-basic science, clinical perspectives, and drug development. Front Physiol. 2014;5:415.","journal-title":"Front Physiol"},{"issue":"11","key":"1278_CR12","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1080\/15216540500380871","volume":"57","author":"P Ascenzi","year":"2005","unstructured":"Ascenzi P, Bocedi A, Visca P, et al. Hemoglobin and heme scavenging. IUBMB Life. 2005;57(11):749\u201359.","journal-title":"IUBMB Life"},{"issue":"6","key":"1278_CR13","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1097\/01.WCB.0000073905.87928.6D","volume":"23","author":"KR Wagner","year":"2003","unstructured":"Wagner KR, Sharp FR, Ardizzone TD, Lu A, Clark JF. Heme and iron metabolism: role in cerebral hemorrhage. J Cereb Blood Flow Metab. 2003;23(6):629\u201352.","journal-title":"J Cereb Blood Flow Metab"},{"issue":"1","key":"1278_CR14","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/S1474-4422(05)70283-0","volume":"5","author":"G Xi","year":"2006","unstructured":"Xi G, Keep RF, Hoff JT. Mechanisms of brain injury after intracerebral haemorrhage. Lancet Neurol. 2006;5(1):53\u201363.","journal-title":"Lancet Neurol"},{"issue":"2","key":"1278_CR15","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1007\/s12028-014-9977-8","volume":"21","author":"JA Gomes","year":"2014","unstructured":"Gomes JA, Selim M, Cotleur A, et al. Brain iron metabolism and brain injury following subarachnoid hemorrhage: iCeFISH-pilot (CSF iron in SAH). Neurocrit Care. 2014;21(2):285\u201393.","journal-title":"Neurocrit Care"},{"issue":"10","key":"1278_CR16","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1002\/acn3.341","volume":"3","author":"C Scherfler","year":"2016","unstructured":"Scherfler C, Schiefecker AJ, Delazer M, et al. Longitudinal profile of iron accumulation in good-grade subarachnoid hemorrhage. Ann Clin Transl Neurol. 2016;3(10):781\u201390.","journal-title":"Ann Clin Transl Neurol"},{"key":"1278_CR17","doi-asserted-by":"crossref","unstructured":"Hutchinson P, O\u2019Phelan K. Participants in the International Multidisciplinary Consensus Conference on Multimodality, M. International multidisciplinary consensus conference on multimodality monitoring: cerebral metabolism. Neurocrit Care. 2014;21 Suppl 2:S148\u201358.","DOI":"10.1007\/s12028-014-0035-3"},{"issue":"3","key":"1278_CR18","first-page":"994","volume":"40","author":"JB Bederson","year":"2009","unstructured":"Bederson JB, Connolly ES Jr, Batjer HH, et al. Guidelines for the management of aneurysmal subarachnoid hemorrhage: a statement for healthcare professionals from a special writing group of the Stroke Council. Am Heart Assoc Stroke. 2009;40(3):994\u20131025.","journal-title":"Am Heart Assoc Stroke"},{"key":"1278_CR19","doi-asserted-by":"crossref","unstructured":"Vergouwen MD. Participants in the International Multi-Disciplinary Consensus Conference on the Critical Care Management of Subarachnoid, H. Vasospasm versus delayed cerebral ischemia as an outcome event in clinical trials and observational studies. Neurocrit Care. 2011;15(2):308\u201311.","DOI":"10.1007\/s12028-011-9586-8"},{"issue":"1","key":"1278_CR20","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/s12028-019-00713-8","volume":"32","author":"M Kofler","year":"2020","unstructured":"Kofler M, Gaasch M, Rass V, et al. The importance of probe location for the interpretation of cerebral microdialysis data in subarachnoid hemorrhage patients. Neurocrit Care. 2020;32(1):135\u201344.","journal-title":"Neurocrit Care"},{"issue":"5","key":"1278_CR21","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1161\/STROKEAHA.110.596874","volume":"42","author":"JM Schmidt","year":"2011","unstructured":"Schmidt JM, Ko SB, Helbok R, et al. Cerebral perfusion pressure thresholds for brain tissue hypoxia and metabolic crisis after poor-grade subarachnoid hemorrhage. Stroke. 2011;42(5):1351\u20136.","journal-title":"Stroke"},{"issue":"3","key":"1278_CR22","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1111\/ane.12258","volume":"130","author":"A Jacobsen","year":"2014","unstructured":"Jacobsen A, Nielsen TH, Nilsson O, Schalen W, Nordstrom CH. Bedside diagnosis of mitochondrial dysfunction in aneurysmal subarachnoid hemorrhage.  Acta Neurol Scand. 2014;130(3):156\u201363.","journal-title":"Acta Neurol Scand"},{"issue":"4","key":"1278_CR23","doi-asserted-by":"publisher","first-page":"2392","DOI":"10.1182\/blood-2007-05-090019","volume":"111","author":"I Theurl","year":"2008","unstructured":"Theurl I, Theurl M, Seifert M, et al. Autocrine formation of hepcidin induces iron retention in human monocytes. Blood. 2008;111(4):2392\u20139.","journal-title":"Blood"},{"issue":"9","key":"1278_CR24","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1007\/s00134-015-3930-y","volume":"41","author":"PJ Hutchinson","year":"2015","unstructured":"Hutchinson PJ, Jalloh I, Helmy A, et al. Consensus statement from the 2014 International Microdialysis Forum. Intensive Care Med. 2015;41(9):1517\u201328.","journal-title":"Intensive Care Med"},{"issue":"1","key":"1278_CR25","doi-asserted-by":"publisher","first-page":"121","DOI":"10.2307\/2531248","volume":"42","author":"SL Zeger","year":"1986","unstructured":"Zeger SL, Liang KY. Longitudinal data analysis for discrete and continuous outcomes. Biometrics. 1986;42(1):121\u201330.","journal-title":"Biometrics"},{"issue":"8","key":"1278_CR26","doi-asserted-by":"publisher","first-page":"857","DOI":"10.2174\/092986707780363014","volume":"14","author":"T Carbonell","year":"2007","unstructured":"Carbonell T, Rama R. Iron, oxidative stress and early neurological deterioration in ischemic stroke. Curr Med Chem. 2007;14(8):857\u201374.","journal-title":"Curr Med Chem"},{"issue":"7","key":"1278_CR27","first-page":"2384","volume":"5","author":"C Munoz-Bravo","year":"2013","unstructured":"Munoz-Bravo C, Gutierrez-Bedmar M, Gomez-Aracena J, Garcia-Rodriguez A, Navajas JF. Iron: protector or risk factor for cardiovascular disease? Still Controversial Nutr. 2013;5(7):2384\u2013404.","journal-title":"Still Controversial Nutr"},{"issue":"5","key":"1278_CR28","doi-asserted-by":"publisher","first-page":"1730","DOI":"10.1111\/j.1471-4159.2007.04976.x","volume":"103","author":"T Moos","year":"2007","unstructured":"Moos T, Rosengren Nielsen T, Skjorringe T, Morgan EH. Iron trafficking inside the brain. J Neurochem. 2007;103(5):1730\u201340.","journal-title":"J Neurochem"},{"issue":"1","key":"1278_CR29","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/2045-8118-8-2","volume":"8","author":"SA Liddelow","year":"2011","unstructured":"Liddelow SA. Fluids and barriers of the CNS: a historical viewpoint. Fluids Barriers CNS. 2011;8(1):2.","journal-title":"Fluids Barriers CNS"},{"issue":"6","key":"1278_CR30","doi-asserted-by":"publisher","first-page":"1830","DOI":"10.1111\/j.1471-4159.1989.tb07264.x","volume":"52","author":"DT Dexter","year":"1989","unstructured":"Dexter DT, Wells FR, Lees AJ, et al. Increased nigral iron content and alterations in other metal ions occurring in brain in Parkinson\u2019s disease. J Neurochem. 1989;52(6):1830\u20136.","journal-title":"J Neurochem"},{"issue":"7","key":"1278_CR31","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1016\/0006-3223(94)90047-7","volume":"35","author":"G Bartzokis","year":"1994","unstructured":"Bartzokis G, Sultzer D, Mintz J, et al. In vivo evaluation of brain iron in Alzheimer\u2019s disease and normal subjects using MRI. Biol Psychiatry. 1994;35(7):480\u20137.","journal-title":"Biol Psychiatry"},{"key":"1278_CR32","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1196\/annals.1306.002","volume":"1012","author":"T Moos","year":"2004","unstructured":"Moos T, Morgan EH. The metabolism of neuronal iron and its pathogenic role in neurological disease: review. Ann N Y Acad Sci. 2004;1012:14\u201326.","journal-title":"Ann N Y Acad Sci"},{"issue":"3","key":"1278_CR33","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1161\/STROKEAHA.115.011956","volume":"47","author":"P Garland","year":"2016","unstructured":"Garland P, Durnford AJ, Okemefuna AI, et al. Heme-hemopexin scavenging is active in the brain and associates with outcome after subarachnoid hemorrhage. Stroke. 2016;47(3):872\u20136.","journal-title":"Stroke"},{"issue":"5","key":"1278_CR34","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1111\/j.1471-4159.2012.07716.x","volume":"121","author":"J Galea","year":"2012","unstructured":"Galea J, Cruickshank G, Teeling JL, et al. The intrathecal CD163-haptoglobin-hemoglobin scavenging system in subarachnoid hemorrhage. J Neurochem. 2012;121(5):785\u201392.","journal-title":"J Neurochem"},{"issue":"Pt 6","key":"1278_CR35","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1042\/BST0361309","volume":"36","author":"I Pelizzoni","year":"2008","unstructured":"Pelizzoni I, Macco R, Zacchetti D, Grohovaz F, Codazzi F. Iron and calcium in the central nervous system: a close relationship in health and sickness. Biochem Soc Trans. 2008;36(Pt 6):1309\u201312.","journal-title":"Biochem Soc Trans"},{"issue":"8","key":"1278_CR36","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1089\/ars.2012.4931","volume":"20","author":"N Singh","year":"2014","unstructured":"Singh N, Haldar S, Tripathi AK, et al. Brain iron homeostasis: from molecular mechanisms to clinical significance and therapeutic opportunities. Antioxid Redox Signal. 2014;20(8):1324\u201363.","journal-title":"Antioxid Redox Signal"},{"issue":"4","key":"1278_CR37","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1016\/j.bbrc.2014.12.073","volume":"456","author":"H Yan","year":"2015","unstructured":"Yan H, Hao S, Sun X, et al. Blockage of mitochondrial calcium uniporter prevents iron accumulation in a model of experimental subarachnoid hemorrhage. Biochem Biophys Res Commun. 2015;456(4):835\u201340.","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"1278_CR38","first-page":"1167","volume":"277","author":"ME Morgan","year":"1996","unstructured":"Morgan ME, Singhal D, Anderson BD. Quantitative assessment of blood-brain barrier damage during microdialysis. J Pharmacol Exp Ther. 1996;277(2):1167\u201376.","journal-title":"J Pharmacol Exp Ther"},{"issue":"1","key":"1278_CR39","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1227\/01.NEU.0000311072.33615.3A","volume":"62","author":"P Mellergard","year":"2008","unstructured":"Mellergard P, Aneman O, Sjogren F, Pettersson P, Hillman J. Changes in extracellular concentrations of some cytokines, chemokines, and neurotrophic factors after insertion of intracerebral microdialysis catheters in neurosurgical patients. Neurosurgery. 2008;62(1):151\u20137 (discussion 7\u20138).","journal-title":"Neurosurgery"},{"issue":"3","key":"1278_CR40","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1161\/01.STR.32.3.636","volume":"32","author":"T Mori","year":"2001","unstructured":"Mori T, Nagata K, Town T, et al. Intracisternal increase of superoxide anion production in a canine subarachnoid hemorrhage model. Stroke. 2001;32(3):636\u201342.","journal-title":"Stroke"},{"issue":"8","key":"1278_CR41","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1161\/01.STR.22.8.971","volume":"22","author":"RL Macdonald","year":"1991","unstructured":"Macdonald RL, Weir BK. A review of hemoglobin and the pathogenesis of cerebral vasospasm. Stroke. 1991;22(8):971\u201382.","journal-title":"Stroke"},{"issue":"5","key":"1278_CR42","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1177\/0271678X16654495","volume":"37","author":"JA Hartings","year":"2017","unstructured":"Hartings JA, Shuttleworth CW, Kirov SA, et al. The continuum of spreading depolarizations in acute cortical lesion development: Examining Leao\u2019s legacy. J Cereb Blood Flow Metab. 2017;37(5):1571\u201394.","journal-title":"J Cereb Blood Flow Metab"},{"issue":"12","key":"1278_CR43","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1136\/jnnp-2014-307711","volume":"85","author":"KP Budohoski","year":"2014","unstructured":"Budohoski KP, Guilfoyle M, Helmy A, et al. The pathophysiology and treatment of delayed cerebral ischaemia following subarachnoid haemorrhage. J Neurol Neurosurg Psychiatry. 2014;85(12):1343\u201353.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"4","key":"1278_CR44","doi-asserted-by":"publisher","first-page":"658","DOI":"10.3171\/jns.2000.93.4.0658","volume":"93","author":"JP Dreier","year":"2000","unstructured":"Dreier JP, Ebert N, Priller J, et al. Products of hemolysis in the subarachnoid space inducing spreading ischemia in the cortex and focal necrosis in rats: a model for delayed ischemic neurological deficits after subarachnoid hemorrhage? J Neurosurg. 2000;93(4):658\u201366.","journal-title":"J Neurosurg"},{"issue":"3","key":"1278_CR45","doi-asserted-by":"publisher","first-page":"R119","DOI":"10.1186\/cc13916","volume":"18","author":"AP Antunes","year":"2014","unstructured":"Antunes AP, Schiefecker AJ, Beer R, et al. Higher brain extracellular potassium is associated with brain metabolic distress and poor outcome after aneurysmal subarachnoid hemorrhage. Crit Care. 2014;18(3):R119.","journal-title":"Crit Care"},{"key":"1278_CR46","doi-asserted-by":"publisher","first-page":"384342","DOI":"10.1155\/2014\/384342","volume":"2014","author":"BA Miller","year":"2014","unstructured":"Miller BA, Turan N, Chau M, Pradilla G. Inflammation, vasospasm, and brain injury after subarachnoid hemorrhage. Biomed Res Int. 2014;2014:384342.","journal-title":"Biomed Res Int"},{"issue":"11","key":"1278_CR47","doi-asserted-by":"publisher","first-page":"3067","DOI":"10.1161\/STROKEAHA.111.617589","volume":"42","author":"M Selim","year":"2011","unstructured":"Selim M, Yeatts S, Goldstein JN, et al. Safety and tolerability of deferoxamine mesylate in patients with acute intracerebral hemorrhage. Stroke. 2011;42(11):3067\u201374.","journal-title":"Stroke"},{"issue":"11","key":"1278_CR48","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1038\/jcbfm.2010.137","volume":"30","author":"JY Lee","year":"2010","unstructured":"Lee JY, Keep RF, He Y, et al. Hemoglobin and iron handling in brain after subarachnoid hemorrhage and the effect of deferoxamine on early brain injury. J Cereb Blood Flow Metab. 2010;30(11):1793\u2013803.","journal-title":"J Cereb Blood Flow Metab"},{"key":"1278_CR49","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/978-3-7091-0661-7_18","volume":"112","author":"JY Lee","year":"2011","unstructured":"Lee JY, Keep RF, Hua Y, Ernestus RI, Xi G. Deferoxamine reduces early brain injury following subarachnoid hemorrhage. Acta Neurochir Suppl. 2011;112:101\u20136.","journal-title":"Acta Neurochir Suppl"},{"issue":"10","key":"1278_CR50","doi-asserted-by":"publisher","first-page":"2861","DOI":"10.1161\/STROKEAHA.107.488015","volume":"38","author":"S Song","year":"2007","unstructured":"Song S, Hua Y, Keep RF, Hoff JT, Xi G. A new hippocampal model for examining intracerebral hemorrhage-related neuronal death: effects of deferoxamine on hemoglobin-induced neuronal death. Stroke. 2007;38(10):2861\u20133.","journal-title":"Stroke"},{"issue":"4","key":"1278_CR51","doi-asserted-by":"publisher","first-page":"ECP4","DOI":"10.3171\/foc.2003.15.4.10","volume":"15","author":"T Nakamura","year":"2003","unstructured":"Nakamura T, Keep RF, Hua Y, et al. Deferoxamine-induced attenuation of brain edema and neurological deficits in a rat model of intracerebral hemorrhage. Neurosurg Focus. 2003;15(4):ECP4.","journal-title":"Neurosurg Focus"}],"container-title":["Neurocritical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12028-021-01278-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12028-021-01278-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12028-021-01278-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,5]],"date-time":"2023-02-05T11:20:51Z","timestamp":1675596051000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12028-021-01278-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,9]]},"references-count":51,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["1278"],"URL":"https:\/\/doi.org\/10.1007\/s12028-021-01278-1","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.740629511.793588051","asserted-by":"object"}]},"ISSN":["1541-6933","1556-0961"],"issn-type":[{"value":"1541-6933","type":"print"},{"value":"1556-0961","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,9]]},"assertion":[{"value":"11 November 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 May 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 August 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors report no conflict of interest concerning the materials or methods used in this study or the findings specified in this article.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of Interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. Approval for this study was granted by the local ethics committee (Medical University of Innsbruck, (AN3898 285\/4.8, AM4091-292\/4.6). Informed consent was obtained from all individual participants included in the study according to local regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval\/informed consent"}}]}}